- Home
- LTH vs TFX Comparison
LTH vs TFX Comparison
Compare LTH & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LTH | TFX |
|---|---|---|
| Founded | 1992 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.8B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | LTH | TFX |
|---|---|---|
| Price | $27.87 | $114.92 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 10 |
| Target Price | $36.79 | ★ $134.88 |
| AVG Volume (30 Days) | ★ 2.3M | 713.6K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 1.19% |
| EPS Growth | ★ 88.46 | N/A |
| EPS | ★ 1.28 | N/A |
| Revenue | $2,913,442,000.00 | ★ $3,189,988,000.00 |
| Revenue This Year | $14.65 | $10.42 |
| Revenue Next Year | $10.92 | $10.58 |
| P/E Ratio | $21.74 | ★ N/A |
| Revenue Growth | ★ 15.77 | 5.42 |
| 52 Week Low | $21.49 | $102.58 |
| 52 Week High | $34.99 | $195.24 |
Technical Indicators
Market Signals| Indicator | LTH | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 65.92 | 49.36 |
| Support Level | $24.46 | $104.21 |
| Resistance Level | $26.29 | $117.14 |
| Average True Range (ATR) | 0.71 | 3.95 |
| MACD | 0.37 | 1.11 |
| Stochastic Oscillator | 91.95 | 83.22 |
Price Performance
Historical ComparisonAbout LTH Life Time Group Holdings Inc.
Life Time Group Holdings Inc is a lifestyle and leisure brand offering health, fitness, and wellness experiences to a community. It is engaged in designing, building, and operating distinctive and large, multi-use sports and athletic, professional fitness, family recreation, and spa centers in a resort-like environment, principally in residential locations of metropolitan areas in the United States and Canada.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.